Our News

Press Release October 20, 2026
CPTx to Present New In Vivo Data for Its In Vivo CAR T Cell Therapies at ESGCT 2026
Read More
Press Release September 8, 2026
CPTx appoints Matt Kane as Chief Financial Officer
Read More
Press Release May 11, 2026
CPTx appoints Edward Rebar as Chief Scientific Officer
Read More
Press Release May 4, 2026
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
Read More
Article January 23, 2026
Hendrik Dietz on “Making CAR T Truly Off the Shelf”
Read More
Press Release October 7, 2025
CPTx Unveils New Data at ESGCT Supporting ssDNA + LNP “Third Path” for In Vivo CAR-T
Read More
Article September 2, 2025
What role is precision medicine playing in transforming cancer treatment — and how are developers adapting?
Read More
Press Release August 14, 2025
CPTx & NanoCell Therapeutics Project Awarded EU Funding for Innovative In Vivo CAR T Therapy with Immune-Silent Single-Stranded DNA
Read More
Article July 1, 2025
Opening new doors to precision medicine with single-stranded DNA (ssDNA): part 2
Read More
Article July 1, 2025
Opening new doors to precision medicine with single-stranded DNA (ssDNA): part I
Read More
Article June 16, 2025
What role is precision medicine playing in transforming cancer treatment — and how are developers adapting?
Read More
Article June 9, 2025
Achieving Targeted Delivery with Nanoscale Systems
Read More

Load more